Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38

REFERENCES

• Amano, Y., S. W. Lee, and A. C. Allison. 1993. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Mol. Pharmacol. 43:176–182.
   PubMed Web of Science ®Google Scholar
• Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286–290.
   PubMed Web of Science ®Google Scholar
• Barnes, P. J.. 1998. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94:557–572.
   PubMed Web of Science ®Google Scholar
• Barrios-Rodiles, M., G. Tiraloche, and K. Chadee. 1999. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha. J. Immunol. 163:963–969.
   PubMed Web of Science ®Google Scholar
• Beato, M., M. Truss, and S. Chavez. 1996. Control of transcription by steroid hormones. Ann. N. Y. Acad. Sci. 784:93–123.
   PubMed Web of Science ®Google Scholar
• Burack, W. R., and A. S. Shaw. 2000. Signal transduction: hanging on a scaffold. Curr. Opin. Cell Biol. 12:211–216.
   PubMed Web of Science ®Google Scholar
• Caelles, C., J. M. Gonzalez-Sancho, and A. Munoz. 1997. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11:3351–3364.
   PubMed Web of Science ®Google Scholar
• Camps, M., A. Nichols, and S. Arkinstall. 2000. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14:6–16.
   PubMed Web of Science ®Google Scholar
• Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670–1674.
   PubMed Web of Science ®Google Scholar
• Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465–470.
   PubMed Web of Science ®Google Scholar
• Crofford, L. J., R. L. Wilder, A. P. Ristimaki, H. Sano, E. F. Remmers, H. R. Epps, and T. Hla. 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J. Clin. Investig. 93:1095–1101.
   PubMed Web of Science ®Google Scholar
• Cuenda, A., G. Alonso, N. Morrice, M. Jones, R. Meier, P. Cohen, and A. R. Nebreda. 1996. Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells. EMBO J. 15:4156–4164.
   PubMed Web of Science ®Google Scholar
• Davis, W., L. R. Stephens, P. T. Hawkins, and J. Saklatvala. 1999. Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42. Biochem. J. 338:387–392.
   PubMed Web of Science ®Google Scholar
• Dean, J. L., M. Brook, A. R. Clark, and J. Saklatvala. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:264–269.
   PubMed Web of Science ®Google Scholar
• Dixon, D. A., C. D. Kaplan, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 2000. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J. Biol. Chem. 275:11750–11757.
   PubMed Web of Science ®Google Scholar
• Freshney, N. W., L. Rawlinson, F. Guesdon, E. Jones, S. Cowley, J. Hsuan, and J. Saklatvala. 1994. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78:1039–1049.
   PubMed Web of Science ®Google Scholar
• Garcia-Gras, E. A., P. Chi, and E. A. Thompson. 2000. Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3′-untranslated region of the mRNA. J. Biol. Chem. 275:22001–22008.
   PubMed Web of Science ®Google Scholar
• Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:211–218.
   PubMed Web of Science ®Google Scholar
• Gessani, S., S. McCandless, and C. Baglioni. 1988. The glucocorticoid dexamethasone inhibits synthesis of interferon by decreasing the level of its mRNA. J. Biol. Chem. 263:7454–7457.
   PubMed Web of Science ®Google Scholar
• Gonzalez, M. V., J. M. Gonzalez-Sancho, C. Caelles, A. Munoz, and B. Jimenez. 1999. Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells. FEBS Lett. 459:272–276.
   PubMed Web of Science ®Google Scholar
• Gou, Q., C. H. Liu, P. Ben-Av, and T. Hla. 1998. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem. Biophys. Res. Commun. 242:508–512.
   PubMed Web of Science ®Google Scholar
• Guan, Z., S. Y. Buckman, B. W. Miller, L. D. Springer, and A. R. Morrison. 1998. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J. Biol. Chem. 273:28670–28676.
   PubMed Web of Science ®Google Scholar
• Han, J., J. D. Lee, Y. Jiang, Z. Li, L. Feng, and R. J. Ulevitch. 1996. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 271:2886–2891.
   PubMed Web of Science ®Google Scholar
• Hla, T., and K. Neilson. 1992. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA 89:7384–7388.
   PubMed Web of Science ®Google Scholar
• Hoover, R. R., and J. Floros. 1999. SP-A 3′-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am. J. Physiol. 276:L917–L924.
   PubMed Web of Science ®Google Scholar
• Jonat, C., H. J. Rahmsdorf, K. K. Park, A. C. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189–1204.
   PubMed Web of Science ®Google Scholar
• Keyse, S. M.. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:186–192.
   PubMed Web of Science ®Google Scholar
• Konig, H., H. Ponta, H. J. Rahmsdorf, and P. Herrlich. 1992. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11:2241–2246.
   PubMed Web of Science ®Google Scholar
• Kunz, D., G. Walker, W. Eberhardt, and J. Pfeilschifter. 1996. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl. Acad. Sci. USA 93:255–259.
   PubMed Web of Science ®Google Scholar
• LaPointe, M. C., and E. Isenovic. 1999. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 33:276–282.
   PubMed Web of Science ®Google Scholar
• Lasa, M., K. R. Mahtani, A. Finch, G. Brewer, J. Saklatvala, and A. R. Clark. 2000. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20:4265–4274.
   PubMed Web of Science ®Google Scholar
• Lee, S. W., A. P. Tsou, H. Chan, J. Thomas, K. Petrie, E. M. Eugui, and A. C. Allison. 1988. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc. Natl. Acad. Sci. USA 85:1204–1208.
   PubMed Web of Science ®Google Scholar
• Matsuura, H., M. Sakaue, K. Subbaramaiah, H. Kamitani, T. E. Eling, A. J. Dannenberg, T. Tanabe, H. Inoue, J. Arata, and A. M. Jetten. 1999. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J. Biol. Chem. 274:29138–29148.
   PubMed Web of Science ®Google Scholar
• McKay, L. I., and J. A. Cidlowski. 1998. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol. Endocrinol. 12:45–56.
   PubMed Web of Science ®Google Scholar
• Miyazawa, K., A. Mori, H. Miyata, M. Akahane, Y. Ajisawa, and H. Okudaira. 1998. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273:24832–24838.
   PubMed Web of Science ®Google Scholar
• Newton, R.. 2000. Molecular mechanisms of glucocorticoid action: what is important?. Thorax 55:603–613.
   PubMed Web of Science ®Google Scholar
• Newton, R., L. M. Kuitert, D. M. Slater, I. M. Adcock, and P. J. Barnes. 1997. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 60:67–78.
   PubMed Web of Science ®Google Scholar
• Newton, R., J. Seybold, L. M. Kuitert, M. Bergmann, and P. J. Barnes. 1998. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J. Biol. Chem. 273:32312–32321.
   PubMed Web of Science ®Google Scholar
• Newton, R., J. Seybold, S. F. Liu, and P. J. Barnes. 1997. Alternate COX-2 transcripts are differentially regulated: implications for post-transcriptional control. Biochem. Biophys. Res. Commun. 234:85–89.
   PubMed Web of Science ®Google Scholar
• Peppel, K., and C. Baglioni. 1991. Deadenylation and turnover of interferon-beta mRNA. J. Biol. Chem. 266:6663–6666.
   PubMed Web of Science ®Google Scholar
• Peppel, K., J. M. Vinci, and C. Baglioni. 1991. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J. Exp. Med. 173:349–355.
   PubMed Web of Science ®Google Scholar
• Poon, M., B. Liu, and M. B. Taubman. 1999. Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol. Cell. Biol. 19:6471–6478.
   PubMed Web of Science ®Google Scholar
• 43. Pouliot, M., J. Baillargeon, J. C. Lee, L. G. Cleland, and M. J. James. 1997. Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. J. Immunol. 158:4930–4937.
   PubMed Web of Science ®Google Scholar
• Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247–1255.
   PubMed Web of Science ®Google Scholar
• Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κ B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91:752–756.
   PubMed Web of Science ®Google Scholar
• Reiser, C. O., T. Lanz, F. Hofmann, G. Hofer, H. D. Rupprecht, and M. Goppelt-Struebe. 1998. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins. Biochem. J. 330:1107–1114.
   PubMed Web of Science ®Google Scholar
• Ridley, S. H., J. L. Dean, S. J. Sarsfield, M. Brook, A. R. Clark, and J. Saklatvala. 1998. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439:75–80.
   PubMed Web of Science ®Google Scholar
• Ridley, S. H., S. J. Sarsfield, J. C. Lee, H. F. Bigg, T. E. Cawston, D. J. Taylor, D. L. DeWitt, and J. Saklatvala. 1997. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158:3165–3173.
   PubMed Web of Science ®Google Scholar
• Ristimaki, A., K. Narko, and T. Hla. 1996. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem. J. 318:325–331.
   PubMed Web of Science ®Google Scholar
• Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. R. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027–1037.
   PubMed Web of Science ®Google Scholar
• Saklatvala, J., L. Rawlinson, R. J. Waller, S. Sarsfield, J. C. Lee, L. F. Morton, M. J. Barnes, and R. W. Farndale. 1996. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J. Biol. Chem. 271:6586–6589.
   PubMed Web of Science ®Google Scholar
• Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin Jr.. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283–286.
   PubMed Web of Science ®Google Scholar
• Scheinman, R. I., A. Gualberto, C. M. Jewell, J. A. Cidlowski, and A. S. Baldwin Jr.. 1995. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol. Cell. Biol. 15:943–953.
   PubMed Web of Science ®Google Scholar
• Shalom-Barak, T., J. Quach, and M. Lotz. 1998. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J. Biol. Chem. 273:27467–27473.
   PubMed Web of Science ®Google Scholar
• Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659–667.
   PubMed Web of Science ®Google Scholar
• Swantek, J. L., M. H. Cobb, and T. D. Geppert. 1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol. Cell. Biol. 17:6274–6282.
   PubMed Web of Science ®Google Scholar
• Takekawa, M., T. Maeda, and H. Saito. 1998. Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J. 17:4744–4752.
   PubMed Web of Science ®Google Scholar
• Tobler, A., R. Meier, M. Seitz, B. Dewald, M. Baggiolini, and M. F. Fey. 1992. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79:45–51.
   PubMed Web of Science ®Google Scholar
• Walker, G., J. Pfeilschifter, and D. Kunz. 1996. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J. Biol. Chem. 271:16679–16687.
   Google Scholar
• Wang, S. W., J. Pawlowski, S. T. Wathen, S. D. Kinney, H. S. Lichenstein, and C. L. Manthey. 1999. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm. Res. 48:533–538.
   PubMed Web of Science ®Google Scholar
• Winzen, R., M. Kracht, B. Ritter, A. Wilhelm, C. Y. Chen, A. B. Shyu, M. Muller, M. Gaestel, K. Resch, and H. Holtmann. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18:4969–4980.
   PubMed Web of Science ®Google Scholar
• Xu, N., P. Loflin, C. Y. Chen, and A. B. Shyu. 1998. A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy. Nucleic Acids Res. 26:558–565.
   PubMed Web of Science ®Google Scholar
• Yang-Yen, H. F., J. C. Chambard, Y. L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205–1215.
   PubMed Web of Science ®Google Scholar
• Yasuda, J., A. J. Whitmarsh, J. Cavanagh, M. Sharma, and R. J. Davis. 1999. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell. Biol. 19:7245–7254.
   PubMed Web of Science ®Google Scholar
• Zhang, J. P., C. K. Wong, and C. W. Lam. 2000. Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils. Clin. Exp. Immunol. 122:20–27.
   PubMed Web of Science ®Google Scholar